D. Watson

发表

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

M. Cronin, S. Paik, G. Tang, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

M. Cronin, S. Paik, G. Tang, 2004, The New England journal of medicine.

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.

Roman Rouzier, Lajos Pusztai, J. Ross, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

S. Shak, J. Baker, D. Watson, 2006, Breast Cancer Research.

Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer.

M. Cronin, D. Watson, D. Dutta, 2007, Clinical chemistry.

Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.

Debora Fumagalli, Norman Wolmark, Soonmyung Paik, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy

Kevin Coombes, Massimo Cristofanilli, Sang-Joon Lee, 2005, Clinical Cancer Research.

Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer

S. Shak, J. Baker, D. Watson, 2011, British Journal of Cancer.

Development and Clinical Validation of a Blood Test for Early Detection of Colorectal Adenomas and Cancer for Screening and Postpolypectomy Surveillance

D. Watson, J. Sninsky, S. Friedland, 2022, Gastro Hep Advances.

Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer

S. Shak, J. Baker, D. Watson, 2011, British Journal of Cancer.

1 A Novel Multi-Biomarker Assay for Non-Invasive 2 Quantitative Monitoring of Kidney Injury 3

M. Sarwal, D. Watson, T. Sigdel, 2019 .

Gene expression and breast cancer mortality in Northern California Kaiser Permanente Patients: A large population-based case control study

S. Shak, J. Baker, D. Watson, 2005 .

Abstract P3-10-01: Quantitative Gene Expression Analysis in a Large Cohort of Estrogen-Receptor Positive Breast Cancers: Characterization of the Tumor Profiles in Younger Patients (≥40 yrs) and in Older Patients (≥70 yrs)

S. Shak, F. Baehner, D. Watson, 2010 .

Prospective clinical study of circulating tumor cells for colorectal cancer screening.

D. Watson, Jen-chia Wu, Ying-Chih Chang, 2018 .

Evaluation of tumor gene expression and K-Ras mutations in FFPE tumor tissue as predictors of response to cetuximab in metastatic colorectal cancer

S. Shak, J. Baker, D. Watson, 2008 .

Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma

R. Emerson, M. Vignali, B. Howie, 2020, BMC Cancer.

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20.

S. Paik, G. Tang, S. Shak, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analytical Validation of Relative Average Telomere Length Measurement in a Clinical Laboratory Environment.

K. Guegler, C. Harley, Jue Lin, 2017, The journal of applied laboratory medicine.

Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue

M. Cronin, G. Sledge, S. Shak, 2007, Breast Cancer Research and Treatment.

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.

D. Kerr, S. Shak, F. Baehner, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analytical validation of the CellMax platform for early detection of cancer by enumeration of rare circulating tumor cells

D. Watson, Z. Gulzar, B. Hsieh, 2019, Journal of circulating biomarkers.

Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer

D. Watson, S. Friedland, H. Lenz, 2019, Clinical and translational gastroenterology.

CTG-19-0055 1..9

D. Watson, S. Friedland, H. Lenz, 2022 .

Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX® Colon Cancer Assay

D. Watson, K. Clark-Langone, C. Sangli, 2010, BMC Cancer.

Multi-gene Rt-pcr assay for predicting recurrence in node negative breast cancer patients-nsabp studies B-20 and B-14

Norman Wolmark, Soonmyung Paik, Gong Tang, 2003 .

Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies

D. Watson, C. Magi-Galluzzi, E. Klein, 2013, BMC Genomics.

A Novel Multi-Biomarker Assay for Non-Invasive Quantitative Monitoring of Kidney Injury

M. Sarwal, D. Watson, T. Sigdel, 2019, Journal of clinical medicine.

Molecular characterization of male breast cancer by standardized quantitative RT-PCR analysis: First large genomic study of 347 male breast cancers compared to 82,434 female breast cancers.

G. Sledge, S. Shak, F. Baehner, 2009, Journal of Clinical Oncology.

Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies

D. Watson, C. Magi-Galluzzi, E. Klein, 2013, BMC Genomics.

Expression of the 21 genes in the Recurrence Score assay and tamoxifen clinical benefit in the NSABP study B-14 of node negative, estrogen receptor positive breast cancer

M. Cronin, S. Paik, G. Tang, 2005 .

Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin.

S. Paik, S. Shak, J. Baker, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A quantitative multigene RT-PCR assay for prediction of recurrence in stage II colon cancer: Selection of the genes in four large studies and results of the independent, prospectively designed QUASAR validation study.

D. Kerr, S. Shak, D. Watson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development and clinical validation of a blood test for early detection of colorectal adenomas and cancer.

D. Watson, J. Sninsky, S. Friedland, 2021 .

Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival

G. Verleden, M. Sarwal, D. Watson, 2019, Journal of clinical medicine.

Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

D. Watson, Yen-Lin Chen, Wen-Chien Huang, 2019, Cancer Immunology, Immunotherapy.

Relationship between tumor gene expression and recurrence in stage II/III colon cancer: Quantitative RT-PCR assay of 757 genes in fixed paraffin-embedded (FPE) tissue.

S. Paik, J. Baker, D. Watson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular Characterization of Breast Cancer Core Biopsy Specimens by Gene Expression Analysis Using Standardized Quantitative RT-PCR.

S. Shak, F. Baehner, D. Watson, 2009 .

Circulating tumor cell count from a blood sample for colorectal cancer (CRC) prevention: A 627-patient prospective study.

D. Watson, Jen-chia Wu, Ying-Chih Chang, 2019, Journal of Clinical Oncology.

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.

D. Kerr, S. Shak, F. Baehner, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.